𝔖 Bobbio Scriptorium

✦ LIBER ✦

Improved survival of multiple myeloma patients with late relapse after high-dose treatment and stem cell support, a population-based study of 348 patients in Denmark in 1994–2004

✍ Scribed by Annette J. Vangsted; Tobias W. Klausen; Niels F. Andersen; Niels Abildgaard; Anne O. Gang; Henrik Gregersen; Ulla Vogel; Peter Gimsing

Book ID: 114794790
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 242 KB
Volume: 85
Category: Article
ISSN: 0902-4441
DOI: 10.1111/j.1600-0609.2010.01465.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose idarubicin, cyclophosphamide a

High-dose idarubicin, cyclophosphamide and melphalan as conditioning for autologous stem cell transplantation increases treatment-related mortality in patients with multiple myeloma: results of a randomised study

✍ R. Fenk; P. Schneider; M. Kropff; A. N. Huenerlituerkoglu; U. Steidl; C. Aul; B. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB

A phase i/ii study of 166holmium-dotmp i

A phase i/ii study of 166holmium-dotmp in combination with high dose chemotherapy and autologous stem cell transplant(Asct) For the treatment of patients with multiple myeloma(Mm)

✍ W. Bensinger; S. Giralt; J. Eary; D. Podoloff; L. Holmberg; R. Alexanian; M. Goo 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 15 KB

Design of the EXercise Intervention afte

Design of the EXercise Intervention after Stem cell Transplantation (EXIST) study: a randomized controlled trial to evaluate the effectiveness and cost-effectiveness of an individualized high intensity physical exercise program on fitness and fatigue in patients with multiple myeloma or (non-) Hodgkin's lymphoma treated with high dose chemotherapy and autologous stem cell transplantation

✍ Saskia Persoon; Marie José Kersten; Mai JM ChinAPaw; Laurien M Buffart; Heleen B 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 256 KB

High dose therapy and autologous stem ce

High dose therapy and autologous stem cell transplant does not improve survival compared with continued combination chemotherapy in people at high risk of relapse after initial treatment of advanced Hodgkin’s lymphoma: Abstracted from: Federico M, Bellei M, Brice P et al. High-dose therapy and autologous stem-cell transplantation versus conventional therapy for patients with advanced Hodgkin’s lymphoma responding to front-line therapy. Journal of Clinical Oncology 2003; 21: 2320–2325

📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 83 KB